Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 12, 2024
03 Enero 2024 - 3:05PM
Business Wire
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today
announced that it will report its fourth quarter and fiscal year
2023 financial results after the market close on Monday, February
12, 2024. The Company will host a conference call the following
morning, Tuesday, February 13, 2024, at 9:00 a.m. ET to discuss
these results.
To participate in the conference call, interested parties must
register in advance by clicking on this link. While it is not
required, it is recommended you join 10 minutes prior to the event
start. Upon registration, all telephone participants will receive a
confirmation email detailing how to join the conference call,
including the dial-in number along with a unique PIN that can be
used to access the call.
To access the conference call via webcast, visit the “Investors”
section of Medpace’s website at investor.medpace.com. The webcast
replay of the call will be available at the same site approximately
one hour after the end of the call.
A supplemental slide presentation will also be available at the
“Investors” section of Medpace’s website prior to the start of the
call.
About Medpace
Medpace is a scientifically-driven, global, full-service
clinical contract research organization (CRO) providing Phase I-IV
clinical development services to the biotechnology, pharmaceutical
and medical device industries. Medpace’s mission is to accelerate
the global development of safe and effective medical therapeutics
through its high-science and disciplined operating approach that
leverages regulatory and therapeutic expertise across all major
areas including oncology, cardiology, metabolic disease,
endocrinology, central nervous system and anti-viral and
anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs
approximately 5,800 people across 41 countries as of September 30,
2023.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240103786137/en/
Investor Contact: Lauren Morris 513.579.9911 x11994
l.morris@medpace.com
Media Contact: Julie Hopkins 513.579.9911 x12627
j.hopkins@medpace.com
Medpace (NASDAQ:MEDP)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Medpace (NASDAQ:MEDP)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
